MRA Scientific Advisory Panel 2022-2023

Organizational Affiliations and Titles are included to identify individuals, however, all individuals listed serve in a personal capacity, and not as a representative of the organization to which they are employed.

Suzanne Topalian, MD — Chair

Professor, Surgery and Oncology
Director, Melanoma Program
Associate Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins Medicine

James Allison, PhD

Regental Professor & Chair, Department of Immunology
Olga Keith Wiess Distinguished University
Chair for Cancer Research
Director, Parker Institute for Cancer Immunotherapy
Executive Director, Immunotherapy Platform
Deputy Director, David H. Koch Center for Applied Research of Genitourinary Cancers
The University of Texas, MD Anderson Cancer Center

Boris Bastian, MD, PhD

Professor, Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished
Professor, Cancer Research
University of California, San Francisco

Gina Fusaro, PhD

Vice President, Development Program Lead
Oncology Clinical Development
Bristol Myers Squibb

Gideon Bollag, PhD

Chief Executive Officer
Plexxikon, Inc.

Glenn Dranoff, MD

Global Head of Immuno-Oncology
Novartis Institutes for Biomedical Research

Gregory Friberg, MD

Vice President Medical Affairs ELMAC Region

Levi Garraway, MD, PhD

Chief Medical Officer and Executive Vice President
Head of Global Product Development
Roche & Genentech

Allan C. Halpern, MD

Chief, Dermatology Service
Associate Chair, Promotions Advisory
Committee, Department of Medicine
Memorial Sloan Kettering Cancer Center

Nageatte Ibrahim, MD

Vice President, Oncology, Global Clinical Development

C. Daniela Robles-Espinoza PhD — Universidad Nacional Autónoma de México (Mexico)

Suzanne Topalian, MD – Johns Hopkins University, MRA Board of Directors, & Chair of MRA’s Scientific Advisory Panel

Howard Kaufman, MD

Head of Research and Development, Immuneering
Lecturer, Surgery, Harvard Medical School

Jeffrey Legos, PhD

Executive Vice President, Global Head of Oncology Development
Novartis Pharmaceuticals Corporation

Richard Marais, PhD, FMedSci

Director, Cancer Research
Professor, Molecular Oncology
UK Manchester Institute

Grant McArthur, PhD, FRACP

Fellow, Royal Australasian College of Physicians
Executive Director
Victorian Comprehensive Cancer Centre
Inaugural Lorenzo Galli Chair of Melanoma and Skin Cancers
University of Melbourne
Senior Principal Research Fellow
National Health & Medical Research Council
Head, Molecular Oncology Laboratory and Cancer Therapeutics Program
Senior Consultant Medical Oncologist, Cancer Medicine
Peter MacCallum Cancer Centre

Ira Mellman, PhD

Vice President, Cancer Immunology

Caroline Robert, MD, PhD

Head, Dermatology Unit
Co-Director, Melanoma Research Unit
Professor, Dermatology
Institute Gustave Roussy

Neal Rosen, MD, PhD

Enid A. Haupt Chair in Medical Oncology
Memorial Sloan Kettering Cancer Center

David Solit, MD

Geoffrey Beene Chair
Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

Tara Withington, CAE

Vice President
Executive Director, Inc.
Executive Director Emeritus
Society for Immunotherapy of Cancer